Clinical trial
Melanole, a Nigella Sativa (Black Seed) Extract for the Treatment of Gastroesophageal Reflux Disease
NCT02587910 is registered in ClinicalTrials.gov with Lebanese American University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melanole, a Nigella Sativa (Black Seed) Extract for the Treatment of Gastroesophageal Reflux Disease
- Lead sponsor
- Lebanese American University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- September 30, 2016
- Enrollment
- 170 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
gerd